ALX ONCOLOGY HOLDINGS INC (ALXO) Stock Income Statement
NASDAQ:ALXO - Nasdaq - US00166B1052 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Cost Of Goods | N/A | N/A | N/A | 0.00 | N/A | |||
| Gross Profit | N/A | N/A | N/A | 0.00 | N/A | |||
| Operating Expenses | 138.00M | 142.00M | 170.00M | 127.44M | 83.56M | |||
| Research and Development | 108.54M | N/A | 141.79M | 98.40M | 60.17M | |||
| Selling, General, and Administrative Expenses | 27.98M | 26.00M | 28.00M | 29.04M | 23.39M | |||
| Operating Income | -138.00M | -142.00M | -170.00M | -127.44M | -83.56M | |||
| Interest Income/Expense | 6.52M | N/A | 9.08M | 4.28M | -10.00K | |||
| Other Income/Expense | -20.00K | 7.00M | 390.00K | -260.00K | 80.00K | |||
| Non Recurring Items | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Income Before Taxes | -130.00M | -135.00M | -161.00M | -123.42M | -83.48M | |||
| Income Tax | N/A | N/A | 0.00 | 60.00K | -20.00K | |||
| Net Income | -130.00M | -135.00M | -161.00M | -123.48M | -83.46M | |||
| EBITDA | -137.13M | -141.13M | -169.16M | -127.10M | -83.51M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.46 | -2.58 | -3.74 | -3.03 | -2.07 | |||
| Non GAAP EPS | -2.47 | -2.60 | -3.75 | -3.03 | -2.06 | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
| Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
| Operating Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
All data in USD